Activating NRF1-BRAF and ATG7-RAF1 fusions in anaplastic pleomorphic xanthoastrocytoma without BRAF p.V600E mutation

Acta Neuropathol. 2016 Nov;132(5):757-760. doi: 10.1007/s00401-016-1616-3. Epub 2016 Sep 13.
No abstract available

Publication types

  • Case Reports
  • Letter
  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adolescent
  • Astrocytoma / genetics*
  • Astrocytoma / pathology
  • Brain Neoplasms / genetics*
  • Brain Neoplasms / pathology
  • DNA Helicases / genetics
  • Exons / genetics
  • Female
  • Glutamic Acid / genetics
  • Humans
  • Male
  • Mitogen-Activated Protein Kinase Kinases / metabolism
  • Mutation / genetics*
  • Nuclear Proteins / genetics
  • Nuclear Respiratory Factor 1 / genetics*
  • Oncogene Fusion / genetics*
  • Proto-Oncogene Proteins B-raf / genetics*
  • Signal Transduction / genetics
  • Time Factors
  • Transcription Factors / genetics
  • Tripartite Motif-Containing Protein 28 / genetics
  • Tumor Suppressor Protein p53 / genetics
  • Valine / genetics
  • World Health Organization
  • Young Adult
  • raf Kinases / genetics*

Substances

  • NRF1 protein, human
  • Nuclear Proteins
  • Nuclear Respiratory Factor 1
  • TP53 protein, human
  • Transcription Factors
  • Tumor Suppressor Protein p53
  • Glutamic Acid
  • TRIM28 protein, human
  • Tripartite Motif-Containing Protein 28
  • BRAF protein, human
  • Proto-Oncogene Proteins B-raf
  • raf Kinases
  • Mitogen-Activated Protein Kinase Kinases
  • SMARCA4 protein, human
  • DNA Helicases
  • Valine